The expected end of enhanced tax credits for ACA plans and “a market-wide morbidity shift” will add to insurers’ financial ...

See here for latest updates on Leon Cooperman's $2.52B Omega Advisors portfolio, including new picks like Sunoco and key insights into his long-term investments.

Analysts have provided Elevance Health with 11 ratings, resulting in a consensus rating of Outperform. The average one-year price target stands at $476.73, suggesting a potential 41.8% upside.

Five cardiology and one radiology advocacy groups have called on Elevance Health to review its latest coverage guidelines for the treatment of varicose veins. The insurer’s guidelines, published ...

Elevance Health (NYSE: ELV) will release second quarter 2025 financial results on July 17, 2025, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its ...

PHILADELPHIA, July 03, 2025 (GLOBE NEWSWIRE) -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Elevance Health, Inc. (“Elevance” or the ...

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ELEVANCE HEALTH, INC. (ELV), CLICK HERE BEFORE JULY 11, 2025 (THE LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.

ELV STOCK LOSS: Elevance Health, Inc. Shareholders are Alerted of Imminent July 11 Class Action Deadline — Contact BFA Law (NYSE:ELV) ...

LOS ANGELES, June 26, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Elevance Health, ...

Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive ...

ELEVANCE HEALTH Hedge Fund Activity We have seen 633 institutional investors add shares of ELEVANCE HEALTH stock to their portfolio, and 942 decrease their positions in their most recent quarter.

Elevance Health, Inc. (NYSE:ELV) is one of billionaire Leon Cooperman’s top stock picks with huge upside potential. On June 4, analysts at Cantor Fitzgerald reiterated their Overweight rating ...